Company intelligence / Profile preview
UPSA
Rueil-Malmaison, Île-de-France, Franceupsa.edu.gh ↗
- Ownership
- Private
- Employees
- ~1900
- Development stage
- Commercial
01
Overview
UPSA develops and markets self-medication products and medical devices across five therapeutic areas. The company has not experienced shortages in its paracetamol-based medicines and maintains continuous production in France.
- Therapeutic areas
- GastroenterologyPulmonologyOtherWomen's HealthNeurology
- Modalities
- Self-medication productsMedical devicesFood supplements
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Institut AnalgésiaRemedee Labs
Beyond the preview
Go deeper on UPSA.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on UPSA.